Overall, this effect is consistent with BC risk-associated variation at this locus reducing expression of the putative tumor-suppressor gene, ATF7IP. Since luciferase assays require expression of an exogenous construct and may not fully recapitulate the native chromosome structure, we validated these results using a CRISPRi approach. Here, ATF7IP is linked to breast cancer.